New data add to the body of evidence favoring the aromatase inhibitor therapy plus ovarian suppression over tamoxifen for ...

Vaginal estrogen therapy appears to be safe after early breast cancer in patients with HR-negative tumors and those with ...

Adding abemaciclib to first-line nonsteroidal aromatase inhibitor treatment does not provide a significant improvement in OS for patients with HR+/HER2- advanced breast cancer, updated data suggest.

In an editorial response to the study, Anawalt said this finding should be taken into consideration when it comes to taking ...

Testosterone boosters act as that much-needed support that many men want but might not speak of. With the best testosterone ...

With its latest line of wellness teas, Numi becomes the first national brand to highlight the mood and energy-enhancing super ...

Perusing the hellscape that is what Twitter has degenerated into as X, I found an alternative cancer cure testimonial, which ...

Testosterone, the key male sex hormone, is vital for various bodily functions. Produced in the testicles, it helps regulate ...

The study population consisted of women newly diagnosed with breast cancer initiating hormonal therapy with aromatase inhibitors or tamoxifen between April 1, 1998, and February 29, 2016. We usedCox ...

The study population consisted of women newly diagnosed with breast cancer initiating hormonal therapy with aromatase inhibitors or tamoxifen between April 1, 1998, and February 29, 2016. We usedCox ...

The global infertility drugs market is expected to witness substantial growth, with the market size projected to increase from USD 3,589.97 million in 2022 to USD 6,453.7 million by 2032, reflecting a ...

Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Verzenio® (abemaciclib; a CDK4/6 inhibitor), ...